Literature DB >> 22798546

Single versus double-unit transfusion policy in hematology.

Andrea Tendas, Pasquale Niscola, Luca Cupelli, Laura Scaramucci, Marco Giovannini, Paolo de Fabritiis.   

Abstract

Mesh：

Year:  2012        PMID： 22798546      PMCID： PMC3396669          DOI： 10.3324/haematol.2012.065516

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  7 in total

1.  Significant reduction of red blood cell transfusion requirements by changing from a double-unit to a single-unit transfusion policy in patients receiving intensive chemotherapy or stem cell transplantation.

Authors:  Martin David Berger; Bernhard Gerber; Kornelius Arn; Oliver Senn; Urs Schanz; Georg Stussi
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

2.  Feasibility of a restrictive red-cell transfusion policy for patients treated with intensive chemotherapy for acute myeloid leukaemia.

Authors:  A J G Jansen; M A A Caljouw; W C J Hop; D J van Rhenen; M R Schipperus
Journal:  Transfus Med       Date:  2004-02       Impact factor: 2.019

3.  Activity-based costs of blood transfusions in surgical patients at four hospitals.

Authors:  Aryeh Shander; Axel Hofmann; Sherri Ozawa; Oliver M Theusinger; Hans Gombotz; Donat R Spahn
Journal:  Transfusion       Date:  2009-12-09       Impact factor: 3.157

4.  Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome.

Authors:  A W Bracey; R Radovancevic; S A Riggs; S Houston; H Cozart; W K Vaughn; B Radovancevic; H A McAllister; D A Cooley
Journal:  Transfusion       Date:  1999-10       Impact factor: 3.157

Review 5.  A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.

Authors:  J Wilson; G L Yao; J Raftery; J Bohlius; S Brunskill; J Sandercock; S Bayliss; P Moss; S Stanworth; C Hyde
Journal:  Health Technol Assess       Date:  2007-04       Impact factor: 4.014

Review 6.  Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review of the literature.

Authors:  Susan D Ross; I Elaine Allen; David H Henry; Christopher Seaman; Brian Sercus; Lawrence T Goodnough
Journal:  Clin Ther       Date:  2006-06       Impact factor: 3.393

7.  Factors associated with transfusion requirements during treatment for acute myelogenous leukemia.

Authors:  G Favre; M Fopp; J Gmür; A Tichelli; M F Fey; A Tobler; E Schatzmann; A Gratwohl
Journal:  Ann Hematol       Date:  1993-10       Impact factor: 3.673
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.